slides · global inventory
All filtered slides
Global slide inventory for the active corpus filters, with each row opening the slide detail view.
Corpus coverage
319,975 slides
319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.
- Total slides
- 319,975
- Described
- 319,974
- Pending
- 1
100%ready for canon
Slide type composition
dynamicclickable
Slide type
Showing 319,974 described slides — 100.0% of 319,975 rendered pages
+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs
Tile area is proportional to slide count. Click a category to open its subtype map.
all document kinds · all orientations
Slide collection
196,441-196,500 of 319,975
40
Note: $ in thousands, unaudited.Sonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations Beat · Action1 hit
41
Sonos | Results Presentation Deck | 41 slidesSonos | Results Presentation Deck | 41 slides · Sonos
Conference presentation Investor relations Beat · Action1 hit
01
Taboola | Mergers and Acquisitions Presentation Deck | 13 slidesTaboola | Mergers and Acquisitions Presentation Deck | 13 slides · Taboola
Shareholder letter Investment bank Beat · Setup1 hit
02
Taboola | Mergers and Acquisitions Presentation Deck | 13 slidesTaboola | Mergers and Acquisitions Presentation Deck | 13 slides · Taboola
Shareholder letter Investment bank Beat · Setup1 hit
03
Confetti background suggests a celebratory tone.Taboola | Mergers and Acquisitions Presentation Deck | 13 slides · Taboola
Shareholder letter Investment bank Beat · Setup1 hit
04
The slide features a purple background with the logos of Yahoo and Taboola, and an inverted image of a person laughing.Taboola | Mergers and Acquisitions Presentation Deck | 13 slides · Taboola
Shareholder letter Investment bank Beat · Setup1 hit
05
The slide uses screenshots of Yahoo's mobile interface with purple boxes highlighting the ad placements.Taboola | Mergers and Acquisitions Presentation Deck | 13 slides · Taboola
Shareholder letter Investment bank Beat · Complication1 hit
06
The slide outlines the value proposition of a specific business partnership.Taboola | Mergers and Acquisitions Presentation Deck | 13 slides · Taboola
Shareholder letter Investment bank Beat · Complication1 hit
07
Uses a before-after comparison to illustrate the scale of the acquisition.Taboola | Mergers and Acquisitions Presentation Deck | 13 slides · Taboola
Shareholder letter Investment bank Beat · Problem (Identify pain)Loop · Before After1 hit
08
The table highlights accretion in both Revenue/Share and Adjusted EBITDA/Share.Taboola | Mergers and Acquisitions Presentation Deck | 13 slides · Taboola
Shareholder letter Investment bank Beat · Problem (Identify pain)Loop · Before After1 hit
09
Taboola | Mergers and Acquisitions Presentation Deck | 13 slidesTaboola | Mergers and Acquisitions Presentation Deck | 13 slides · Taboola
Shareholder letter Investment bank Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
10
Taboola | Mergers and Acquisitions Presentation Deck | 13 slidesTaboola | Mergers and Acquisitions Presentation Deck | 13 slides · Taboola
Shareholder letter Investment bank Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
11
Taboola | Mergers and Acquisitions Presentation Deck | 13 slidesTaboola | Mergers and Acquisitions Presentation Deck | 13 slides · Taboola
Shareholder letter Investment bank Beat · Resolution1 hit
12
The slide serves as a disclosure of the underlying logic for a hypothetical financial scenario.Taboola | Mergers and Acquisitions Presentation Deck | 13 slides · Taboola
Shareholder letter Investment bank Beat · Resolution1 hit
13
Standard financial disclosure slide explaining why GAAP reconciliations for projections are not provided.Taboola | Mergers and Acquisitions Presentation Deck | 13 slides · Taboola
Shareholder letter Investment bank Beat · Resolution1 hit
01
The slide uses a visual collage of product UI to establish brand identity and service scope.Talkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations 1 hit
02
Talkspace | Results Presentation Deck | 11 slidesTalkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations 1 hit
03
The slide uses three distinct bar charts to compare year-over-year performance.Talkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations Beat · Attention1 hit
04
The slide uses a 2x2 grid layout to present four distinct strategic pillars.Talkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
05
Revenue chart is a stacked bar chart; Gross Profit chart is a combo chart with bars for profit and dots for margin percentage.Talkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
06
Operating Expenses chart is a stacked bar chart showing OpEx vs SBC + Non-Recurring expenses.Talkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
07
DTE stands for Direct-to-Enterprise; MBH & EAP stands for Mental Health Benefit & Employee Assistance Program.Talkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
08
The advertising spend chart shows percentage decreases quarter-over-quarter.Talkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
09
Talkspace | Results Presentation Deck | 11 slidesTalkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
10
Talkspace | Results Presentation Deck | 11 slidesTalkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations 1 hit
11
Includes footnotes explaining financial income and non-recurring expenses.Talkspace | Results Presentation Deck | 11 slides · Talkspace
Conference presentation Investor relations 1 hit
01
Theravance Biopharma | Investor Conference Presentation Deck | 44 slidesTheravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
02
Poster #117Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
03
Theravance Biopharma | Investor Conference Presentation Deck | 44 slidesTheravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
04
Theravance Biopharma | Investor Conference Presentation Deck | 44 slidesTheravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
05
Theravance Biopharma | Investor Conference Presentation Deck | 44 slidesTheravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
06
The slide uses anatomical diagrams to illustrate the spread of alpha-synuclein (labeled 'α') across the nervous system for three different neurodegenerative conditions.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
07
The slide uses a biological process diagram to explain the mechanism of action for midodrine and droxidopa in the context of autonomic disorders.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
08
Includes a screenshot of a BMC Neurology paper and a bar chart showing subgroup analysis of OHSA scores.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
09
The slide uses a biological process diagram to explain how different drugs (agonists, precursors, reuptake inhibitors) affect sympathetic signaling to blood vessels.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
10
The slide uses a biological process diagram to explain the drug's mechanism of action.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
11
The slide uses a process flow diagram to show how patients transition from Study 0169 to 0170.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
12
The slide shows a significant increase in Norepinephrine levels with Ampreloxetine treatment compared to placebo.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
13
Study 0169 data showing significant increases in Norepinephrine and decreases in DHPG across three patient cohorts.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Aha Moment1 hit
14
The chart illustrates a worsening of blood pressure in the placebo group compared to the treatment group.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Before After1 hit
15
The slide uses a bar chart with error bars to show treatment effects. 'Worsening' is indicated by a downward arrow on the right.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Before After1 hit
16
Includes a footer with abbreviations for BP, DHPG, MSA, NE, and nOH.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
17
Poster #106Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
18
Theravance Biopharma | Investor Conference Presentation Deck | 44 slidesTheravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
19
The slide highlights the failure of Study 0169 and the subsequent early termination of Study 0170.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
20
The slide outlines a complex clinical trial structure involving rollovers from Study 0169 and de novo participants, leading into a randomized withdrawal period.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
21
The slide uses a flow diagram to illustrate study design and participant disposition.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
22
The slide provides a standard 'Table 1' style clinical trial baseline characteristic summary.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
23
The slide shows patient counts and percentages for study completion and various reasons for discontinuation.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
24
The slide uses a forest plot to visualize the odds ratio (0.60) with a 95% confidence interval (0.27, 1.29) crossing the null value of 1.0.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
25
Uses a visual comparison to explain the biological mechanism of action.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
26
The slide highlights the MSA subgroup with a blue box, suggesting a focus on this specific finding.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · KPI Overview1 hit
27
The slide uses forest plots to compare treatment effects (ampreloxetine vs placebo) across different patient populations (Overall, MSA, PD, PAF).Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · KPI Overview1 hit
28
The slide includes a table of adverse events and bulleted takeaways regarding clinical safety parameters.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
29
The slide includes a list of authors for a related longitudinal analysis.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
30
Poster #4Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
31
Theravance Biopharma | Investor Conference Presentation Deck | 44 slidesTheravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
32
The slide uses a bulleted list to frame the clinical trial narrative from failure to a focused subgroup opportunity.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
33
The slide uses a biological mechanism diagram to illustrate the drug's effect on norepinephrine reuptake.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
34
The slide outlines a clinical trial program involving three studies (0169, 0170, 0171) with specific eligibility criteria and endpoints for a longitudinal analysis.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit